ES2148670T3 - Sustituto de la leche y procedimiento de fabricacion. - Google Patents

Sustituto de la leche y procedimiento de fabricacion.

Info

Publication number
ES2148670T3
ES2148670T3 ES96202669T ES96202669T ES2148670T3 ES 2148670 T3 ES2148670 T3 ES 2148670T3 ES 96202669 T ES96202669 T ES 96202669T ES 96202669 T ES96202669 T ES 96202669T ES 2148670 T3 ES2148670 T3 ES 2148670T3
Authority
ES
Spain
Prior art keywords
substitute
milk
whey
solids
batch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96202669T
Other languages
English (en)
Inventor
Heinz Wyss
Hans Engel
Martinas Kuslys
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of ES2148670T3 publication Critical patent/ES2148670T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/04—Whey; Whey preparations containing non-milk components as source of fats or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Feed For Specific Animals (AREA)

Abstract

SUSTITUTO DE LECHE ELABORADO A PARTIR DE LECHE EN POLVO DESCREMADA Y, EVENTUALMENTE, DE LACTOSUERO EN POLVO Y SUSTITUIDO EN PARTE POR LACTOSA. PRESENTA LA VENTAJA DE QUE EVITA O REDUCE LA PRESENCIA DE IONES CALCIO CA++ LIBRES EN LA SOLUCION SUSCEPTIBLES DE DESESTABILIZAR LA MICELA DE CASEINA. EL SUSTITUTO CONTIENE DE UN 10 A UN 12 % DE SOLIDOS DE LECHE DESCREMADA, DE UN 5 A UN 9 % DE SOLIDOS DE LACTOSUERO, DE UN 7 A UN 10 % DE MATERIA GRASA, DE UN 68 A UN 80 % DE AGUA, DE UN 0,01 A UN 0,03 % DE CARRAGENATOS Y DE UN 0,1 A UN 3 % DE AGENTE SECUESTRADOR DEL CALCIO. EL PROCEDIMIENTO DE FABRICACION DEL SUSTITUTO DE LECHE A PARTIR DE LACTOSUERO COMPRENDE LA DISOLUCION SECUENCIAL DE LOS COMPONENTES EN DOS FASES EN "BATCH" O EN UNA FASE EN "BATCH" SEGUIDA DE UNA FASE EN LINEA, QUE GARANTIZAN LA ESTABILIDAD TERMICA DEL PRODUCTO A PESAR DE LA PRESENCIA EN CANTIDAD IMPORTANTE DE PROTEINAS DE LACTOSUERO.
ES96202669T 1996-09-24 1996-09-24 Sustituto de la leche y procedimiento de fabricacion. Expired - Lifetime ES2148670T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96202669A EP0832565B1 (fr) 1996-09-24 1996-09-24 Substitut de lait et procédé de fabrication

Publications (1)

Publication Number Publication Date
ES2148670T3 true ES2148670T3 (es) 2000-10-16

Family

ID=8224419

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96202669T Expired - Lifetime ES2148670T3 (es) 1996-09-24 1996-09-24 Sustituto de la leche y procedimiento de fabricacion.

Country Status (21)

Country Link
US (1) US5906847A (es)
EP (1) EP0832565B1 (es)
JP (1) JP3974980B2 (es)
CN (1) CN1072898C (es)
AP (1) AP1001A (es)
AR (1) AR008642A1 (es)
AT (1) ATE193636T1 (es)
AU (1) AU730051B2 (es)
BR (1) BR9704801A (es)
CA (1) CA2214478C (es)
CZ (1) CZ292019B6 (es)
DE (1) DE69608801T2 (es)
DK (1) DK0832565T3 (es)
ES (1) ES2148670T3 (es)
MY (1) MY117113A (es)
NZ (1) NZ328682A (es)
PA (1) PA8438801A1 (es)
PE (1) PE102698A1 (es)
PL (1) PL187397B1 (es)
RU (1) RU2204258C2 (es)
ZA (1) ZA977836B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245379B1 (en) * 1998-09-30 2001-06-12 The Iams Company Method of administering a milk substitute to critical care animals
US6168141B1 (en) * 1999-03-22 2001-01-02 Artur G. Zimmer Apparatus for treatment of fluent materials
ATE320720T1 (de) * 1999-08-17 2006-04-15 Nestle Sa Verfahren zur herstellung von einem ersatzstoff für kondensmilch
US6521278B1 (en) * 2000-09-12 2003-02-18 Mars, Incorporated Food materials with improved flavor and functionality due to size reduction in a modified atmosphere
WO2005017090A1 (en) * 2003-07-24 2005-02-24 Cargill, Incorporated Food composition
US20060177549A1 (en) * 2003-07-24 2006-08-10 John Van De Sype Food composition
US20080098900A1 (en) * 2006-11-01 2008-05-01 Babatunde Aremu Beverage manufacture using a static mixer
AU2008268916A1 (en) * 2007-06-22 2008-12-31 Starbucks Corporation, D/B/A Starbucks Coffee Company Beverage and method of making same
EP2197469A2 (en) 2007-09-11 2010-06-23 Mondobiotech Laboratories AG Use of nf-kappab inhibitor sn50 and optionally angiotensin iii as therapeutic agents in the treatment of eg hbv infection
US20100204113A1 (en) 2007-09-11 2010-08-12 Dorian Bevec Use of stresscopin-related peptide as a therapeutic agent
US20100204149A1 (en) 2007-09-11 2010-08-12 Dorian Bevec Use of octreotide as a therapeutic agent
WO2009043440A2 (en) 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent
JP2010539052A (ja) 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのペプチドの使用
WO2009046845A2 (en) 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Use of a lactoferrin partial peptide peptide as a therapeutic agent
CA2698666A1 (en) 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2009046848A1 (en) 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent
WO2009046875A2 (en) 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Combination of splenopentin and thymopentin and the use thereof in medicine
KR20100057642A (ko) 2007-09-11 2010-05-31 몬도바이오테크 래보래토리즈 아게 치료제로서의 ｃｎｐ-２２ 단독 또는 피살라에민과 배합된 이의 용도
KR20100061477A (ko) 2007-09-11 2010-06-07 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드 ａｓｎ-ａｓｐ-ａｓｐ-ｃｙｓ-ｇｌｕ-ｌｅｕ-ｃｙｓ-ｖａｌ-ａｓｎ-ｖａｌ-ａｌａ-ｃｙｓ-ｔｈｒ-ｇｌｙ-ｃｙｓ-ｌｅｕ-ｏｈ 단독 또는 펩티드 ｔｈｒ-ｔｈｒ-ｓｅｒ-ｇｌｎ-ｖａｌ-ａｒｇ-ｐｒｏ-ａｒｇ-ｏｈ와의 배합물의 용도
JP2010539017A (ja) 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 単独でまたはニューロキニン−ｂと組み合わせて用いる、治療剤としてのｒｆｒｐの使用
KR20100069651A (ko) 2007-09-11 2010-06-24 몬도바이오테크 래보래토리즈 아게 Ｈｃｍｖ 감염의 치료를 위한 치료제로서의 ｂｕｂｕｃ 및 임의의 ｅａａ－ｍａｒｔ１（２６－３５）의 용도
EP2187940B1 (en) 2007-09-11 2013-01-30 Mondobiotech Laboratories AG Use of urocortin optionally together with corticotropin-releasing factor as therapeutic agents
EP2187907A2 (en) 2007-09-11 2010-05-26 Mondobiotech Laboratories AG Use of tyr-w-mif-1 and urocortin 2 as therapeutic agents
EP2190533A2 (en) 2007-09-11 2010-06-02 Mondobiotech Laboratories AG Use of a peptide as a therapeutic agent
WO2009043519A2 (en) 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
KR20100057640A (ko) 2007-09-11 2010-05-31 몬도바이오테크 래보래토리즈 아게 치료제로서의 인슐린 ｃ-펩티드 단독 또는 ｇｌｐ-1과의 배합물의 용도
CA2699073A1 (en) 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
US20100184708A1 (en) 2007-09-11 2010-07-22 Dorian Bevec Use of gly-pro-glu-oh (gpe) as a therapeutic agent
RU2010114025A (ru) 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) ПРИМЕНЕНИЕ ПЕПТИДА Gly-Arg-Gly-Asp-Asn-Pro В КАЧЕСТВЕ ТЕРАПЕВТИЧЕСКОГО СРЕДСТВА
KR101015970B1 (ko) 2008-02-29 2011-02-23 대한민국 젖먹이 송아지를 위한 모유수준 대용유 조성물, 이를이용하여 대용유를 제조하는 방법 및 송아지의 대용유포유방법
US20100204129A1 (en) 2008-09-09 2010-08-12 Dorian Bevec Use of a peptide as a therapeutic agent
CN101990956B (zh) * 2009-08-25 2012-09-05 内蒙古伊利实业集团股份有限公司 一种无脂无糖酸乳饮料及其制备方法
AU2010290505B2 (en) * 2009-09-02 2014-04-17 Meiji Co., Ltd. Condensed milk-like whey composition and method for producing same
JP5436246B2 (ja) * 2010-01-28 2014-03-05 株式会社明治 乳製品製造用組成物、乳製品およびその製造方法
NL2005496C2 (en) * 2010-10-11 2012-04-12 Friesland Brands Bv Sweet particulate fat-containing powder, its preparation and its use.
CN102283290B (zh) * 2011-07-04 2012-10-17 广东东泰乳业有限公司 一种豆基婴儿配方粉及其制备方法
EP2814335A4 (en) * 2012-02-16 2015-03-25 Nestec Sa PROCESS FOR PRODUCING MILK-LIKE BEVERAGES
RU2608151C1 (ru) * 2015-12-07 2017-01-16 Дмитрий Геннадьевич Бурцев Способ производства молочного продукта
CN116250569A (zh) * 2023-04-07 2023-06-13 宜兰食品工业股份有限公司 一种羊奶复原乳及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2516355A (en) * 1947-05-20 1950-07-25 Earl N Howard Fire protection for curing tobacco in barns
US3174866A (en) * 1962-01-26 1965-03-23 Borden Co Preparing hypoallergenic milk protein composition
US3201245A (en) * 1963-04-10 1965-08-17 American Home Prod Method of preparing liquid infant formula
JPS5264455A (en) * 1975-11-25 1977-05-27 Asahi Denka Kogyo Kk Method of producing concentrated milkklike composition
ES8301593A1 (es) * 1981-11-16 1983-01-01 Union Ind Y Agro Ganader S A U Procedimiento de obtencion de una leche humanizada adiciona-da de nucleotidos con destino a la alimentacion infantil.
US4446164A (en) * 1982-03-25 1984-05-01 Brog Roy A Whey based imitation milk compositions
EP0321603A1 (fr) * 1987-12-23 1989-06-28 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
RU2045188C1 (ru) * 1991-06-06 1995-10-10 Всероссийский научно-исследовательский институт молочной промышленности Способ получения заменителя цельного молока
NL9300855A (nl) * 1993-05-17 1994-12-16 Friesland Frico Domo Coop Werkwijze voor de bereiding van geëvaporeerde melk.
RU2060675C1 (ru) * 1994-02-25 1996-05-27 Научно-производственное объединение "Экотех" - товарищество с ограниченной ответственностью Способ получения заменителя цельного молока для молодняка сельскохозяйственных животных (вариант)

Also Published As

Publication number Publication date
MY117113A (en) 2004-05-31
AR008642A1 (es) 2000-02-09
PL187397B1 (pl) 2004-06-30
BR9704801A (pt) 1998-10-27
CZ292019B6 (cs) 2003-07-16
PL322239A1 (en) 1998-03-30
CN1179891A (zh) 1998-04-29
ZA977836B (en) 1999-03-01
MX9707223A (es) 1998-03-31
RU2204258C2 (ru) 2003-05-20
AP9701106A0 (en) 1997-10-31
NZ328682A (en) 1999-01-28
CA2214478C (en) 2006-11-28
AU730051B2 (en) 2001-02-22
JP3974980B2 (ja) 2007-09-12
AP1001A (en) 2001-08-14
DE69608801T2 (de) 2000-10-12
EP0832565A1 (fr) 1998-04-01
US5906847A (en) 1999-05-25
CN1072898C (zh) 2001-10-17
CZ301097A3 (cs) 1998-04-15
DE69608801D1 (de) 2000-07-13
AU3840397A (en) 1998-03-26
DK0832565T3 (da) 2000-11-20
CA2214478A1 (en) 1998-03-24
PA8438801A1 (es) 2000-05-24
ATE193636T1 (de) 2000-06-15
JPH10108620A (ja) 1998-04-28
EP0832565B1 (fr) 2000-06-07
PE102698A1 (es) 1999-01-27

Similar Documents

Publication Publication Date Title
ES2148670T3 (es) Sustituto de la leche y procedimiento de fabricacion.
DE59807890D1 (de) Saures getränk
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
DK0486863T3 (da) Antacidum-præparat med forlænget opholdstid i maven
DE69203958D1 (de) Produktionssystem zur Herstellung von Kleidung und anderen Produkten.
BR9703653A (pt) Queijo de derretimento controlado
DE69007958D1 (de) Nichtmilchhaltige Cremes.
WO2002085328A3 (de) Verfahren zur herstellung eines wirkstoffkonzentrats sowie wirkstoffkonzentrat
ES510028A0 (es) "procedimiento para la bioconversion de pulpa celulosica industrial en productos enriquecidos en proteinas".
FI910411A0 (fi) Dietlivsmedel foer patienter med njursvikt.
BR0108506A (pt) Método para preparação de leite em pó
FR2714063B1 (fr) Procédé de préparation de collagène à partir de cnidaires, et compositions obtenues utilisables en cosmétique.
FR2677012B1 (fr) Dioxyde de titane sous forme de plaquettes et son procede de preparation.
ZA81473B (en) 5-amino-tetayole derivatives of retinoic acids, their preparation and pharmaceutical formulations containg these derivatives
MY132803A (en) Protein composition, preparation and use thereof, and products containing same and preparation thereof
ES523951A0 (es) Mejoras introducidas en el objeto de la patente principal n. 501.433 por: procedimiento de tratamiento de la leche
RU97110475A (ru) Мазь-бальзам "фролова" для лечения ожогов и инфицированных ран различной этиологии
FR2723680B1 (fr) Complement nutritionnel absorbable pour l'equilibre quotidien de l'homme.
RU96112885A (ru) Молочный напиток "женьшеневый"
Akkus et al. Biomechanical analysis of the effects of single high dose vitamin D 3 on fracture healing in a healthy rabbit model
Vessey et al. Thrombosis and oral contraception
Glod et al. Foreign body reaction in a dacron-meshed hemi-implant
Thibault The dynamics of plan implementation in national sport organizations
IT8941553A0 (it) Dispositivo di allacciatura per calzature sportive, in particolare per stivali da motocross e stivale includente detto dispositivo.
Chouinard et al. Antimanic effect of clonazepam.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 832565

Country of ref document: ES